Correction to: Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation. . Circulation 2025;151:e30.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Correction to: Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation. Circulation 2025;151:e30.
PMID: 39836761